Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy

1. Shapiro, J, van Lanschot, JJB, Hulshof, MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 2015; 16: 1090–1098.
Google Scholar | Crossref | Medline | ISI2. Yang, H, Liu, H, Chen, Y, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol 2018; 36: 2796–2803.
Google Scholar | Crossref | Medline3. Rice, TW, Chen, LQ, Hofstetter, WL, et al. Worldwide Esophageal Cancer Collaboration: pathologic staging data. Dis Esophagus 2016; 29: 724–733.
Google Scholar | Crossref | Medline4. Rice, TW, Ishwaran, H, Hofstetter, WL, et al. Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus 2016; 29: 897–905.
Google Scholar | Crossref | Medline5. National Comprehensive Cancer Network : NCCN Clinical Practice guidelines in oncology: esophageal and esophagogastric junction cancers version 2 2020, https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf
Google Scholar6. Lerut, T, Nafteux, P, Moons, J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 2004; 240: 962–974.
Google Scholar | Crossref | Medline7. Nakagawa, S, Kanda, T, Kosugi, SI, et al. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 2004; 198: 205–211.
Google Scholar | Crossref | Medline | ISI8. Hsu, PK, Huang, CS, Wu, YC, et al. Open versus thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma. World J Surg 2014; 38: 402–409.
Google Scholar | Crossref | Medline | ISI9. Mariette, C, Balon, JM, Piessen, G, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer-Am Cancer Soc 2003; 97: 1616–1623.
Google Scholar | Crossref | Medline10. Liu, Q, Cai, XW, Wu, B, et al. Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy. PLoS ONE 2014; 9: e0097225.
Google Scholar11. Parry, K, Visser, E, van Rossum, PS, et al. Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent. Ann Surg Oncol 2015; 22: S1292–S1300.
Google Scholar | Crossref | Medline12. Blom, RL, Lagarde, SM, Oudenaarde, K, et al. Survival after recurrent esophageal carcinoma has not improved over the past 18 years. Ann Surg Oncol 2013; 20: 2693–2698.
Google Scholar | Crossref | Medline13. Su, X-D, Zhang, D-K, Zhang, X, et al. Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma. J Thorac Dis 2014; 6: 949–957.
Google Scholar | Medline14. Peyre, CG, Hagen, JA, DeMeester, SR, et al. Predicting systemic disease in patients with esophageal cancer after esophagectomy a multinational study on the significance of the number of involved lymph nodes. Ann Surg 2008; 248: 979–985.
Google Scholar | Crossref | Medline15. Shim, YM, Kim, HK, Kim, K. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma. J Thorac Oncol 2010; 5: 707–712.
Google Scholar | Crossref | Medline16. Weiser, MR, Landmann, RG, Kattan, MW, et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol 2008; 26: 380–385.
Google Scholar | Crossref | Medline17. Sweldens, C, Peeters, S, van Limbergen, E, et al. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram. Cancer J 2014; 20: 1–7.
Google Scholar | Crossref | Medline18. Zhang, WY, Chen, XX, Chen, WH, et al. Nomograms for predicting risk of locoregional recurrence and distant metastases for esophageal cancer patients after radical esophagectomy. BMC Cancer 2018; 18: 1–8.
Google Scholar | Crossref | Medline19. Xiao, ZF, Yang, ZY, Liang, J, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 2003; 75: 331–336.
Google Scholar | Crossref | Medline | ISI20. Chen, J, Liu, S, Pan, J, et al. The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg 2009; 36: 480–486.
Google Scholar | Crossref | Medline21. Chen, J, Zhu, J, Pan, J, et al. Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus. Ann Thorac Surg 2010; 90: 435–442.
Google Scholar | Crossref | Medline22. Xu, S, Ross, C, Raebel, MA, et al. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health 2010; 13: 273–277.
Google Scholar | Crossref | Medline | ISI23. Lerut, T, Moons, J, Coosemans, W, et al. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification. Ann Surg 2009; 250: 798–807.
Google Scholar | Crossref | Medline24. Tanaka, H, Ohira, M, Kubo, N, et al. Association of location of lymph node metastases with postoperative recurrence of esophageal squamous cell carcinoma. Anticancer Res 2012; 32: 3421–3426.
Google Scholar | Medline25. Situ, D, Wang, J, Lin, P, et al. Do tumor location and grade affect survival in pT3N0M0 esophageal squamous cell carcinoma. ? J Thorac Cardiovasc Surg 2013; 146: 45–51.
Google Scholar | Crossref | Medline26. Hsu, PK, Wang, BY, Huang, CS, et al. Prognostic Factors for Post-recurrence Survival in Esophageal Squamous Cell Carcinoma Patients with Recurrence after Resection. J Gastrointest Surg 2011; 15: 558–565.
Google Scholar | Crossref | Medline27. Yi, M, Meric-Bernstam, F, Kuerer, HM, et al. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol 2012; 30: 600–607.
Google Scholar | Crossref | Medline28. Werkhoven, E, Van Hart, G, Tinteren, H, et al. Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial. Radiother Oncol 2011; 100: 101–107.
Google Scholar | Crossref | Medline29. Rodrigues, G, Warner, A, Zindler, J, et al. A clinical nomogram and recursive partitioning analysis to determine the risk of regional failure after radiosurgery alone for brain metastases. Radiother Oncol 2014; 111: 52–58.
Google Scholar | Crossref | Medline30. Jones, GD, Brandt, WS, Shen, R, et al. A genomic-pathologic annotated risk model to predict recurrence in early-stage lung adenocarcinoma. JAMA Surg 2020; 156: e205601.
Google Scholar | Crossref31. Deng, W, Yang, J, Ni, W, et al. Postoperative radiotherapy in pathological T2–3N0M0 thoracic esophageal squamous cell carcinoma: interim report of a prospective, phase III, randomized controlled study. Oncologist 2020; 25: e701–e708.
Google Scholar | Crossref | Medline32. Yu, S, Zhang, W, Ni, W, et al. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy. Radiother Oncol 2019; 140: 159–166.
Google Scholar | Crossref | Medline33. Zhang, W, Liu, XX, Xiao, Z, et al. Postoperative intensity-modulated radiotherapy improved survival in lymph node-positive or stage III thoracic esophageal squamous cell carcinoma. Oncol Res Treat 2015; 38: 97–102.
Google Scholar | Crossref | Medline34. Chen, J, Pan, J, Zheng, X, et al. Number and location of positive nodes, postoperative radiotherapy, and survival after Esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012; 82: 475–482.
Google Scholar | Crossref | Medline35. Xiao, ZF, Yang, ZY, Miao, YJ, et al. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phys 2005; 62: 82–90.
Google Scholar | Crossref | Medline | ISI36. Kang, J, Chang, JY, Sun, X, et al. Role of postoperative concurrent chemoradiotherapy for esophageal carcinoma: a meta-analysis of 2165 patients. J Cancer 2018; 9: 584–593.
Google Scholar | Crossref | Medline37. Kelly, RJ, Ajani, JA, Kuzdzal, J, et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med 2021; 384: 1191–1203.
Google Scholar | Crossref | Medline38. Patel, K, Askari, A, Moorthy, K. Long-term oncological outcomes following completely minimally invasive esophagectomy versus open esophagectomy. Dis Esophagus off J Int Soc Dis Esophagus 2020; 33: 1–10.
Google Scholar

留言 (0)

沒有登入
gif